ACNB(ACNB)
ACNB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $168M | $172M |
| Low | $162M | $168M |
| High | $171M | $176M |
| EBITDA Avg | $62M | $63M |
| Low | $60M | $62M |
| High | $63M | $65M |
| EBIT Avg | $57M | $58M |
| Low | $55M | $57M |
| High | $58M | $59M |
| Net Income Avg | $55M | $56M |
| Low | $54M | $56M |
| High | $56M | $57M |
| EPS Avg | $5.40 | $5.48 |
| Low | $5.28 | $5.40 |
| High | $5.48 | $5.57 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $43M | $42M | $42M | $43M | $43M | $43M |
| Low | $41M | $41M | $41M | $42M | $42M | $42M |
| High | $44M | $43M | $43M | $44M | $44M | $43M |
| EBITDA Avg | $16M | $16M | $16M | $16M | $16M | $16M |
| Low | $15M | $15M | $15M | $16M | $16M | $15M |
| High | $16M | $16M | $16M | $16M | $16M | $16M |
| EBIT Avg | $14M | $14M | $14M | $15M | $15M | $14M |
| Low | $14M | $14M | $14M | $14M | $14M | $14M |
| High | $15M | $14M | $14M | $15M | $15M | $15M |
| Net Income Avg | $14M | $14M | $13M | $15M | $15M | $14M |
| Low | $14M | $13M | $13M | $14M | $14M | $14M |
| High | $15M | $14M | $14M | $15M | $15M | $14M |
| EPS Avg | $1.38 | $1.35 | $1.30 | $1.40 | $1.41 | $1.37 |
| Low | $1.33 | $1.30 | $1.25 | $1.35 | $1.36 | $1.32 |
| High | $1.41 | $1.37 | $1.32 | $1.43 | $1.43 | $1.39 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |